Meyka AI API is live for developers.Start building.
Advertisement
Molecular Partners AG

Molecular Partners AG (MLLCF) Stock Overview

Explore Molecular Partners AG’s financial performance, market position, analyst ratings, and future outlook.

MLLCF●PNK
HealthcareBiotechnology
$4.85
$0.00(0.00%)
U.S. Market opens in 7h 36m
Advertisement

Molecular Partners AG (MLLCF)

Meyka AI Score

Z

Key Financials

Market Cap181.9M
P/E Ratio-2.51
EPS (TTM)$-1.95
ROE-0.66%
Fundamental Analysis

AI Price Forecasts

1 Month$2.38
3 Months$3.05
1 Year Target$2.57

MLLCF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Molecular Partners AG (MLLCF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 93.54, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $2.57.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.51 and a market capitalization of 181.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
90.20%
3-Month Change
115.56%
6-Month Change
16.87%
Year-to-Date (YTD) Change
38.57%
1-Year Change
14.93%
3-Year Change
-20.23%
5-Year Change
-81.49%
All-Time (Max) Change
-78.56%

Contact Information

https://www.molecularpartners.com
41 44 755 77 00
Wagistrasse 14, Schlieren, NaN, 8952

Company Facts

158 Employees
IPO DateJun 14, 2018
CountryCH
Actively Trading

Frequently Asked Questions